Literature DB >> 17406825

Factors prognostic of survival in patients awaiting liver transplantation for end-stage liver disease.

Haldun Selcuk1, Irfan Uruc, Mehtap Akcil Temel, Serkan Ocal, Bulent Huddam, Murat Korkmaz, Hakan Unal, Mehmet Kanbay, Nurten Savas, Gurden Gur, Ugur Yilmaz, Mehmet Haberal.   

Abstract

In this study, we investigated possible independent predictive factors for survival, other than MELD score, in patients with cirrhosis. We reviewed the serum sodium, cholesterol, albumin, and platelet levels of 99 patients with cirrhosis and investigated the possible correlation of these parameters with survival period. We found that 77% and 81% of patients with cirrhosis were hypocholesterolemic and hypoalbuminemic, respectively. We noted that the survival time of 6 months in patients with serum sodium levels <125 mM at the time of admission to the study was 27% less than that in patients with sodium levels >130 mM. Patients with cirrhosis and serum sodium levels >130 mM survived for more than 1 year (95% CI). MELD scores of patients with serum sodium levels >130, between 125 and 129, and <125 mM were 15.8 to 19.9, 19.7 to 23.6, and 23.3 to 27.2, respectively (95% CI). In conclusion, we suggest that although all of these parameters are correlated with survival in patients with cirrhosis, the serum sodium level is the most accurate prognostic factor and a valid tool for predicting survival when considered in combination with the MELD score.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17406825     DOI: 10.1007/s10620-007-9742-3

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  13 in total

1.  Persistent ascites and low serum sodium identify patients with cirrhosis and low MELD scores who are at high risk for early death.

Authors:  Douglas M Heuman; Souheil G Abou-Assi; Adil Habib; Leslie M Williams; R Todd Stravitz; Arun J Sanyal; Robert A Fisher; Anastasios A Mihas
Journal:  Hepatology       Date:  2004-10       Impact factor: 17.425

2.  Serum sodium predicts mortality in patients listed for liver transplantation.

Authors:  Scott W Biggins; Harry J Rodriguez; Peter Bacchetti; Nathan M Bass; John P Roberts; Norah A Terrault
Journal:  Hepatology       Date:  2005-01       Impact factor: 17.425

3.  Addition of serum sodium into the MELD score predicts waiting list mortality better than MELD alone.

Authors:  Andres E Ruf; Walter K Kremers; Lila L Chavez; Valeria I Descalzi; Luis G Podesta; Federico G Villamil
Journal:  Liver Transpl       Date:  2005-03       Impact factor: 5.799

4.  Increased natriuretic efficiency of furosemide in rats with carbon tetrachloride-induced cirrhosis.

Authors:  T E Jonassen; A M Sørensen; J S Petersen; F Andreasen; S Christensen
Journal:  Hepatology       Date:  2000-06       Impact factor: 17.425

5.  Transection of the oesophagus for bleeding oesophageal varices.

Authors:  R N Pugh; I M Murray-Lyon; J L Dawson; M C Pietroni; R Williams
Journal:  Br J Surg       Date:  1973-08       Impact factor: 6.939

6.  Serum lipid and lipoprotein patterns in patients with liver cirrhosis and chronic active hepatitis.

Authors:  C Cicognani; M Malavolti; A M Morselli-Labate; L Zamboni; C Sama; L Barbara
Journal:  Arch Intern Med       Date:  1997-04-14

7.  Hyponatremia impairs early posttransplantation outcome in patients with cirrhosis undergoing liver transplantation.

Authors:  Maria-Carlota Londoño; Mónica Guevara; Antoni Rimola; Miquel Navasa; Pilar Taurà; Antoni Mas; Juan-Carlos García-Valdecasas; Vicente Arroyo; Pere Ginès
Journal:  Gastroenterology       Date:  2006-04       Impact factor: 22.682

8.  Temporal relationship between hyperaldosteronism, sodium retention and ascites formation in rats with experimental cirrhosis.

Authors:  W Jiménez; A Martinez-Pardo; V Arroyo; J Bruix; A Rimola; J Gaya; F Rivera; J Rodés
Journal:  Hepatology       Date:  1985 Mar-Apr       Impact factor: 17.425

9.  Model for end-stage liver disease (MELD) and allocation of donor livers.

Authors:  Russell Wiesner; Erick Edwards; Richard Freeman; Ann Harper; Ray Kim; Patrick Kamath; Walter Kremers; John Lake; Todd Howard; Robert M Merion; Robert A Wolfe; Ruud Krom
Journal:  Gastroenterology       Date:  2003-01       Impact factor: 22.682

10.  Child-Turcotte-Pugh versus MELD score as a predictor of outcome after elective and emergent surgery in cirrhotic patients.

Authors:  Neil Farnsworth; Shawn P Fagan; David H Berger; Samir S Awad
Journal:  Am J Surg       Date:  2004-11       Impact factor: 2.565

View more
  5 in total

Review 1.  Abnormalities of Lipoprotein Levels in Liver Cirrhosis: Clinical Relevance.

Authors:  Graziella Privitera; Luisa Spadaro; Simona Marchisello; Giuseppe Fede; Francesco Purrello
Journal:  Dig Dis Sci       Date:  2017-11-25       Impact factor: 3.199

2.  Combined MELD and blood lipid level in evaluating the prognosis of decompensated cirrhosis.

Authors:  Ming Jiang; Fei Liu; Wu-Jun Xiong; Lan Zhong; Wen Xu; Fei Xu; Yan-Bing Liu
Journal:  World J Gastroenterol       Date:  2010-03-21       Impact factor: 5.742

3.  Evaluation of a scoring system for assessing prognosis in pediatric acute liver failure.

Authors:  Brandy R Lu; Jane Gralla; Edwin Liu; Emily L Dobyns; Michael R Narkewicz; Ronald J Sokol
Journal:  Clin Gastroenterol Hepatol       Date:  2008-10       Impact factor: 11.382

4.  Comparison of four models for end-stage liver disease in evaluating the prognosis of cirrhosis.

Authors:  Ming Jiang; Fei Liu; Wu-Jun Xiong; Lan Zhong; Xi-Mei Chen
Journal:  World J Gastroenterol       Date:  2008-11-14       Impact factor: 5.742

Review 5.  Impact of pretransplant hepatic encephalopathy on liver posttransplantation outcomes.

Authors:  Lewis W Teperman
Journal:  Int J Hepatol       Date:  2013-11-13
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.